These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26266379)

  • 1. A Taiwanese Nationwide Cohort Study Shows Interferon-Based Therapy for Chronic Hepatitis C Reduces the Risk of Chronic Kidney Disease.
    Chen YC; Hwang SJ; Li CY; Wu CP; Lin LC
    Medicine (Baltimore); 2015 Aug; 94(32):e1334. PubMed ID: 26266379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence rates of tuberculosis in chronic hepatitis C infected patients with or without interferon based therapy: a population-based cohort study in Taiwan.
    Lin SY; Chen TC; Lu PL; Lin CY; Lin WR; Yang YH; Chen YH
    BMC Infect Dis; 2014 Dec; 14():705. PubMed ID: 25523602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan.
    Hsu CS; Kao JH; Chao YC; Lin HH; Fan YC; Huang CJ; Tsai PS
    Aliment Pharmacol Ther; 2013 Aug; 38(4):415-23. PubMed ID: 23802888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD.
    Park H; Chen C; Wang W; Henry L; Cook RL; Nelson DR
    Hepatology; 2018 Feb; 67(2):492-504. PubMed ID: 28873225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of rheumatoid arthritis in patients with hepatitis C virus infection receiving interferon-based therapy: a retrospective cohort study using the Taiwanese national claims database.
    Tung CH; Lai NS; Li CY; Tsai SJ; Chen YC; Chen YC
    BMJ Open; 2018 Jul; 8(7):e021747. PubMed ID: 30037875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-hepatitis C virus therapy in chronic kidney disease patients improves long-term renal and patient survivals.
    Chen YC; Li CY; Tsai SJ; Chen YC
    World J Clin Cases; 2019 Jun; 7(11):1270-1281. PubMed ID: 31236391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients.
    Hsu YC; Lin JT; Ho HJ; Kao YH; Huang YT; Hsiao NW; Wu MS; Liu YY; Wu CY
    Hepatology; 2014 Apr; 59(4):1293-302. PubMed ID: 24122848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nationwide cohort study suggests that nucleos(t)ide analogue therapy decreases dialysis risk in Taiwanese chronic kidney disease patients acquiring hepatitis B virus infection.
    Chen YC; Li CY; Tsai SJ; Chen YC
    World J Gastroenterol; 2018 Feb; 24(8):917-928. PubMed ID: 29491685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of interferon-based therapy with risk of autoimmune diseases in patients with chronic hepatitis C virus infection: A population-based Taiwanese cohort study.
    Chou SM; Yeh HJ; Lin TM; Chang YS; Hsu HC; Shen YC; Kuo TT; Chen JH; Chen SC; Chang CC
    Front Immunol; 2022; 13():992819. PubMed ID: 36275719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection.
    Su TH; Liu CJ; Tseng TC; Chou SW; Liu CH; Yang HC; Wu SJ; Chen PJ; Chen DS; Chen CL; Kao JH
    Aliment Pharmacol Ther; 2019 Feb; 49(3):331-339. PubMed ID: 30592071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Add-on neurological benefits of antiviral therapy in HCV patients with chronic kidney disease - a nationwide cohort study.
    Lin MS; Chen TH; Lin WY; Liu CH; Hsieh YY; Chiu WN; Chang CH; Chen MY; Chung CM; Lin YS
    BMC Gastroenterol; 2017 Aug; 17(1):99. PubMed ID: 28814273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-based therapy decreases risks of hepatocellular carcinoma and complications of cirrhosis in chronic hepatitis C patients.
    Hsu CS; Huang CJ; Kao JH; Lin HH; Chao YC; Fan YC; Tsai PS
    PLoS One; 2013; 8(7):e70458. PubMed ID: 23894660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Different Types of Interferon-Associated Retinopathy in Patients with Chronic Hepatitis C Virus Infection Treated with Pegylated Interferon Plus Ribavirin.
    Wu CM; Su FH; Muo CH; Huang JC; Wu MM; Yeh CC
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33799370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma.
    Hsu YC; Ho HJ; Wu MS; Lin JT; Wu CY
    Hepatology; 2013 Jul; 58(1):150-7. PubMed ID: 23389758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus itself is a causal risk factor for chronic kidney disease beyond traditional risk factors: a 6-year nationwide cohort study across Taiwan.
    Chen YC; Chiou WY; Hung SK; Su YC; Hwang SJ
    BMC Nephrol; 2013 Sep; 14():187. PubMed ID: 24011024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer.
    Su TH; Tseng TC; Liu CJ; Chou SW; Liu CH; Yang HC; Chen PJ; Chen DS; Chen CL; Kao JH
    Int J Cancer; 2020 Aug; 147(3):901-908. PubMed ID: 31853972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients.
    Hung CH; Lu SN; Wang JH; Hu TH; Chen CH; Huang CM; Lee CM
    Antivir Ther; 2011; 16(7):959-68. PubMed ID: 22024511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Unraveled Link Between Antiviral Therapy and Heart Failure Hospitalization in Chronic Hepatitis C Virus Infection　- A Nationwide Cohort Study.
    Lin MS; Chung CM; Chang ML; Chen MY; Chang ST; Chu PH; Chen TH; Lin WY; Huang TJ; Lin YS
    Circ J; 2018 May; 82(6):1623-1631. PubMed ID: 29503408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 13-year nationwide cohort study of chronic kidney disease risk among treatment-naïve patients with chronic hepatitis B in Taiwan.
    Chen YC; Su YC; Li CY; Hung SK
    BMC Nephrol; 2015 Jul; 16():110. PubMed ID: 26199000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality.
    Liu CJ; Chu YT; Shau WY; Kuo RN; Chen PJ; Lai MS
    Gut; 2014 Mar; 63(3):506-14. PubMed ID: 23676440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.